Add Yahoo as a preferred source to see more of our stories on Google. Discover what the condition is and how it could impact your health. If you’ve been active on social media or reading the news ...

Shares of Corcept Therapeutics CORT were up 10.4% yesterday after the company announced that it will resubmit the new drug ...

Add Yahoo as a preferred source to see more of our stories on Google. Schumer shared in the News Not Noise newsletter late last week, that she has exogenous Cushing syndrome that was brought on by ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

Please provide your email address to receive an email when new articles are posted on . “[We have seen] improvement in outcome since 2000, but mortality is still unacceptably high,” Padiporn ...

The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...

Cushing’s syndrome has general symptoms that are similar to several other health conditions and, as a result, it can be difficult to diagnose. It is often a long process that requires a series of ...

Please provide your email address to receive an email when new articles are posted on . To achieve optimal outcomes in Cushing’s syndrome, both clinicians and patients need to be prepared for the type ...

Cushing Syndrome is a relatively uncommon hormonal disorder that arises as a consequence of chronically elevated levels of cortisol in the body. Cortisol serves to play a vital role in controlling ...